Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $6.8000 (4.29%) ($6.1750 - $6.8000) on Wed. Jun. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.75% (three month average) | RSI | 71 | Latest Price | $6.8000(4.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 5.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 8.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(37%) ARKK(35%) IBB(35%) ARKG(33%) XAR(32%) | Factors Impacting ATRA price | ATRA will decline at least -2.875% in a week (0% probabilities). VIXM(-41%) VXX(-31%) UNG(-25%) USO(-22%) XOP(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.875% (StdDev 5.75%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.96(14.09%) | 10 Day Moving Average | $5.7(19.3%) | 20 Day Moving Average | $5.39(26.16%) | To recent high | -31% | To recent low | 45% | Market Cap | $505m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |